// App-Quantinova.ai

5388 : Association of baseline systemic corticosteroid use with time to next treatment in patients with advanced melanoma, non-small cell lung cancer or urothelial cancer receiving cancer immunotherapy in US clinical practice

Researchers

Presenter

  • Alexandra Drakaki

Principal Investigators

  • Preet K. Dhillon

  • Heather Wakelee

  • Stephen Y. Chui

  • Jinjoo Shim

  • Matthew Kent

  • Viraj Degaonkar

  • Tien Hoang

  • Virginia McNally

  • Patricia Luhn

  • Ralf Gutzmer

Medical Centers

  • University of Southern California, Los Angeles, CA

  • Genentech, Inc., South San Francisico, CA

  • Stanford Medical School, Stanford, CA

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Genesis Research, Hoboken, NJ

  • Roche Products Ltd., Welwyn Garden City, United Kingdom

  • Hannover Medical School, Hannover, Germany

Locations

  • United States

  • Switzerland

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Bladder Cancer

  • Lung Cancer

  • Melanoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Techniclone TNT

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved